Congress Needs to Improve Access to Cancer Care

A diagnosis of multiple myeloma used to be a death sentence. Survival rates for the blood cancer were just two to three years. But a wave of new medicine has dramatically improved outcomes for people who have it, increasing the odds that patients will live longer than five years.

Unfortunately, insurance benefits have not caught up with those medical breakthroughs. Sadly, many patients face higher out-of-pocket costs for the most effective treatments just because that medicine is covered differently by their health plan than traditional IV chemotherapy. For many, these treatments are the only option to extend their life.

Read full article here.